K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 758.00
-1.00 (-0.13%)
Apr 17, 2026, 3:30 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.8 billion as of April 17, 2026. Its market cap has decreased by -29.98% in one year.
Market Cap
8.80B
Enterprise Value
7.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
758.00
Market Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.80B, a decrease of -19.61%. That is a compound annual growth rate of -8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 8.80B | 14.90% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 11.13B |
| Kubota Pharmaceutical Holdings | 10.96B |
| BrightPath Biotherapeutics | 8.92B |
| Carna Biosciences | 8.29B |
| MEDINET | 7.99B |
| CellSource | 7.96B |
| StemCell Institute | 7.95B |
| ADR120S | 7.36B |